ArticleOncogenesis2019

Inhibition of HGF/MET signaling decreases overall tumor burden and blocks malignant conversion in Tpl2-related skin cancer.

Nicole F Bonan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.